期刊文献+

Expression of tissue inhibitor of metalloproteinase-1 in progression muscular dystrophy 被引量:1

Expression of tissue inhibitor of metalloproteinase-1 in progression muscular dystrophy
下载PDF
导出
摘要 Objective Tissue inhibitor of metalloproteinase-1 (TIMP-1) is a muhifunctional protein that has thc capacity to modify cellular activities and to modulate matrix turnover. This paper revealed the contributive role of TIMP-1 in progressive muscular dystrophy (PMD). Methods We examined the expression and cellular localization of TIMP-1 protein using biopsied frozen muscle from patients with Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD) , congenital muscular dystrophy (CMD) by immunohistochemistry, double immunofluorescence and Western blot analysis. Results The results of immunohistochemistry and double immunofluorescence showed that TIMP-1 was positive only in vascular endothelial cells of normal muscles. Immunohistochemistry and Western blot analysis showed that the staining intensity was distinctly increased in some dystrophic muscles of PMD for TIMP-1. Double immunofluorescence revealed that TIMP-1 strongly expressed in the regenerating muscle fibers, macrophages and macrophage infiltrating necrotic fibers. Some activated fibroblasts in endomysium and perimysium of DMD and CMD muscles were also positive for TIMP- 1. Conclusion The functional consequence of overexpression of TIMP-1 in the dystrophic muscles is unknown, but the elevated local expression of TIMP-1 in diseased muscles of PMD and their distinct distribution pattern provide evidence that TIMP-1 may participate in the pathogenesis of PMD. Objective Tissue inhibitor of metalloproteinase-1 (TIMP-1) is a muhifunctional protein that has thc capacity to modify cellular activities and to modulate matrix turnover. This paper revealed the contributive role of TIMP-1 in progressive muscular dystrophy (PMD). Methods We examined the expression and cellular localization of TIMP-1 protein using biopsied frozen muscle from patients with Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD) , congenital muscular dystrophy (CMD) by immunohistochemistry, double immunofluorescence and Western blot analysis. Results The results of immunohistochemistry and double immunofluorescence showed that TIMP-1 was positive only in vascular endothelial cells of normal muscles. Immunohistochemistry and Western blot analysis showed that the staining intensity was distinctly increased in some dystrophic muscles of PMD for TIMP-1. Double immunofluorescence revealed that TIMP-1 strongly expressed in the regenerating muscle fibers, macrophages and macrophage infiltrating necrotic fibers. Some activated fibroblasts in endomysium and perimysium of DMD and CMD muscles were also positive for TIMP- 1. Conclusion The functional consequence of overexpression of TIMP-1 in the dystrophic muscles is unknown, but the elevated local expression of TIMP-1 in diseased muscles of PMD and their distinct distribution pattern provide evidence that TIMP-1 may participate in the pathogenesis of PMD.
出处 《Neuroscience Bulletin》 SCIE CAS CSCD 2006年第2期85-90,共6页 神经科学通报(英文版)
关键词 muscular dystrophy tissue inhibitor of metalloproteinase-1 Western blot muscular dystrophy tissue inhibitor of metalloproteinase-1 Western blot
  • 相关文献

参考文献10

  • 1Hayakawa T, Yamashita K, Tanzawa K, et al. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 ( TIMP-1 ) for a wide range of cells: a possible new growth factor in serum. FEBS,1992, 298( 1 ) : 29-32.
  • 2Lim MS, Guedez L, Stetler-Stevenson WG, et al. Tissue inhibitor of metalloproteinase-2 induces apoptosis in human T lymphocytes.Ann NY Acad Sci, 1999, 878: 522-523.
  • 3Thorgeirsson UP, Yoshiji H, Sinha CC, et al. Breast cancer,tumor neovasculature and the effect of tissue inhibitor of metalloproteinases-1 (TIMP-1) on angiogenesis. In Vivo, 1996, 10:137144.
  • 4Selman M, Ruiz V, Cabrera S, et al. TIMP-1 ,-2 ,-3 ,and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? AJP-Lung Cell and Mol Physiol, 2000, 279 ( 3 ) :L562 -L574.
  • 5Kikuchi K, Kadono T, Furue M, et al. Tissue inhibitor of metalloproteinase 1 ( TIMP-1 ) may be an autocrine growth factor in scleroderma fibroblasts. J Invest Dermatol, 1997, 108:281-284.
  • 6Mattila L, Airola K, Ahonen M, et al. Activation of tissue inhibitors of metalloproteinases-3 ( TIMP-3 ) mRNA expression in scleroderma skin fibroblasts. J Invest Dermatol, 1998, 110 : 416-421.
  • 7Mautino G, Henriquet C, Gougat C, et al. Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteinase-9 by macrophages in asthma. Lab Invest,1999, 79:39-47.
  • 8Zhang Y, McCluskey K, Fujii K, et cd. Differential regulation of monocytes matrix metalloproteinase and TIMP-1 production by TNF-α, granulocyte- macrophage CSF, and IL-1 through prostaghndin-dependent and -independent mechanisms. J Immunol, 1998, 161 :3071 -3076.
  • 9Guerin, CW, Holland PC. Synthesis and secretion of matrix-degrading metalloproteases by human skeletal muscle satellite cells.Dev Dyn ,1995 ,202: 91-99.
  • 10Koskinen SOA, Wang W, Ahtikoski AM, et al. Acute exercise induced changes in rat skeletal muscle mRNAs and proteins regulating type Ⅳ collagen content. Am J Physiol Regul Integr Comp Physiol, 2001,280(5) : R1292-1300.

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部